IT
Immutrix Therapeutics, Inc.
SEC filingOther · Rapid City, SD
Amount raised$480Ksold at filing
Total offering$5M$4.5M still open
Investors in the raise1count reported to the SEC
FiledSep 22, 2025first sale Sep 18, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dan L SmithExecutive Officer
Brad L HennrichDirector
Rich L OttoDirector
Carol L RaeDirector
Lonnie Lien BookbinderDirector
Ronald L ShapeExecutive Officer, Director
Stephanie Lien D'UrsoDirector
Russell Lien McCullohDirector
Executive officers, directors and promoters as listed on the Form D.